Opening https://www.businesswire.com/news/home/20240430870310/en/Qlaris-Bio-Completes-24-Million-Series-B-Financing-Round-to-Advance-QLS%E2%80%91111-a-First-in-class-Iop-lowering-Drug-Candidate-for-Glaucoma